Targeted Treatment for IDH2-Mutated AML
EP. 1: Case Review: IDH2-Mutated Acute Myeloid Leukemia
August 8th 2018
EP. 2: Molecular Testing for Newly Diagnosed AML
August 8th 2018
EP. 3: Treatment of Patients With Chemo-Refractory AML
August 8th 2018
EP. 4: Enasidenib in Relapsed/Refractory Mutant IDH2 AML
August 8th 2018
EP. 5: Advantages of Oral Enasidenib in IDH2-Mutated AML
August 8th 2018
EP. 6: Toxicity Management in the Treatment of R/R AML
August 8th 2018
EP. 7: Targeted Therapies and the Treatment of AML
August 8th 2018
